heart rate variability is one of the better biometric indicators of nervous system health. the variation between heartbeats is governed by the autonomic nervous system — specifically the balance between sympathetic activation and parasympathetic recovery. high HRV means the nervous system is flexible, able to shift between states as needed. low HRV means it's stuck — typically in sympathetic dominance.
the biohacking community's interest in HRV is legitimate. it's a proxy for something real: the body's ability to move between the ⏸ and ▶. wearables measure it reasonably well over time. the trend line is more useful than any single reading.
the question is what you do with the information.
what HRV is actually measuring
HRV is downstream of the HPA axis. the hypothalamic-pituitary-adrenal pathway — which governs cortisol production — is the primary determinant of autonomic nervous system state. when cortisol is elevated and the HPA axis is running hot, the sympathetic system is dominant. HRV drops. this is the mechanism.
it means that a consistently low HRV reading is telling you that your HPA axis baseline is too high — that the nervous system has recalibrated toward sustained activation. this is the stuck switch in physiological terms: the ⏸ button is harder to access because the system has learned to stay in sympathetic mode.
the wearable tells you this accurately. what it can't tell you is what to do about it. and most HRV advice — sleep more, meditate, reduce alcohol — addresses the edges of the problem without touching the root.
cortisol suppresses parasympathetic activity. when the HPA axis is chronically activated, cortisol remains elevated even during rest periods. this is why people with high work stress can sleep eight hours and still wake with low HRV — the parasympathetic system was unable to fully activate because cortisol was suppressing it. the sleep quantity was right. the HPA axis baseline wasn't.
what actually moves the baseline
three interventions have the strongest evidence for HPA axis recalibration — which is what improving chronic low HRV requires.
sleep timing consistency. not sleep duration — timing. the circadian rhythm governs cortisol's natural diurnal pattern. when sleep timing is irregular, the cortisol pattern is disrupted, baseline rises, and HRV suffers. consistent sleep and wake times are the single most impactful intervention. the evidence for this is strong and the mechanism is well-understood.
overall load reduction. the HPA axis is responding to accumulated demand — not just acute stressors. reducing the total number of demands on the system, even by small amounts, lowers the average cortisol load over time. this is the "try easier" principle stated physiologically. the system needs less asked of it, not better performance from it.
adaptogen support. this is where the plant protocol enters. ashwagandha has the most specific and well-documented evidence for HPA axis recalibration among plant-based interventions.
chandrasekhar et al (2012) — 60-day double-blind randomised controlled trial — found 27.9% reduction in serum cortisol in the ashwagandha group vs 7.9% in placebo. mechanism: modulation of glucocorticoid receptors, reducing the sensitivity and reactivity of the cortisol response. this is HPA axis recalibration — not cortisol suppression, but restoration of appropriate responsiveness.
what doesn't directly move it
some popular HRV improvement recommendations address downstream effects rather than the root. box breathing and cold exposure activate the parasympathetic system acutely — which produces a temporary HRV improvement during and immediately after the practice. the effect is real. but for someone with a chronically elevated HPA axis baseline, acute parasympathetic activation is working against a current that resets between sessions.
these practices are not wrong. they're useful as part of a broader approach to nervous system health. but they're not the intervention for a stuck HPA axis baseline. they're managing the consequence rather than addressing the calibration.
this is the equivalent of measuring the symptom (low HRV) and treating the symptom (acute parasympathetic activation) rather than addressing the cause (HPA axis running hot). the wearable is useful precisely because it shows you the symptom clearly. the treatment needs to go one level deeper.
the plant protocol in context
for someone with consistently low HRV who has already addressed sleep timing and is managing overall load: ashwagandha at a standardised dose (KSM-66 is the most-studied extract) for 60 days is the most evidence-backed addition to the protocol.
the result won't be visible immediately. HRV changes slowly because it's tracking a baseline, not an acute state. the 60-day timeline in the chandrasekhar trial reflects a genuine recalibration of the HPA axis — not a temporary manipulation.
this is the difference between the stuck switch and a bad day. a bad day changes HRV acutely. the stuck switch has shifted the baseline. moving the baseline takes the kind of consistent, sustained input that ashwagandha is specifically designed to provide.
the wearable has been telling you the same thing for three months. you've tried everything on the list. the number isn't moving.
same. the baseline is the thing. ⏸read more about the stuck switch — why the nervous system gets stuck and about what ashwagandha and biohacking have in common — the mechanism behind the HPA axis work is the same in both conversations.